Atlas Trials

Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

Clinical trial NCT03822858 · AVAILABLE

Trial details

NCT number
NCT03822858
Sponsor
Tisch Multiple Sclerosis Research Center of New York
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Multiple Sclerosis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.